AU
Nuo Therapeutics, Inc.
AURX · OTC
$1.25 +0.00% (+$0.00)
1M +5.04%
Market Cap $60.5M
P/E Ratio -
Div. Yield -
ROE -
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 11.64x
P/E N/A
EV/FFO N/A
Growth
100 /100
Growing Rev. growth 209.05%
EPS growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Gross margin 64.11%
FCF margin 47.06%
Net margin 38.70%
Quality
21 /100
Poor ROIC 153.00%
Asset turnover 1.98x
ROA 76.63%
Debt
24 /100
High Current ratio 1.28x
Int. coverage -25.05x
Debt/Equity N/A
Stability
40 /100
Moderate Beta -104.09x
Profitable years 0
Rev. volatility 178.40%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about AURX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
David E. Jorden
Employees
10
Headquarters
Houston
Upcoming events
02 DEC
Earnings
Upcoming earnings report